ArticleInternational journal of molecular sciences2020

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Takahiro Ozutsumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.